Shares of Sun Pharmaceutical Industries and Ranbaxy Laboratories have rallied over 5% each in otherwise subdued market on CNBC-TV18 report that suggests that a team of US FDA inspectors, which recently conducted a surprise audit on a Gujarat unit of ... Business Standard India, 1 month ago
Foreign investors accumulate Ranbaxy shares - Hindu Business Line, 1 hour ago
Metal, healthcare scrips down; witness selling pressure - India Infoline, 1 month ago
3 images for "ranbaxy industries"
Ranbaxy Laboratories, which is in the process of being acquired by larger rival Sun Pharmaceutical Industries, has reported a profit in its second quarter. The company on Tuesday reported a profit of Rs 4.78 billion ($78 million), compared with a ...Business Today India, 3 days ago Ranbaxy posts first profit in 6 quarters Economic Times, 2 days ago Strong India, West Europe business helps Ranbaxy post first profit in six quarters DNA India, 2 days ago Reuters Summit - Hong Kong-China stock link-up undermined by tax issue Yahoo! Maktoob News, 3 days ago
Results Today: Lupin , Ranbaxy , ING Vysya Bank , Nestle , Jubilant Life Sciences , ABB , VST Industries, SRF, PI Industries, Parry Sugar, Oriental Hotel, Global Offshore, CCL Products, Mangalam Cement Official says -Finance ministry to seek ...Moneycontrol.com, 3 days ago Stocks in news: Hero, Dr Reddy's Labs, ONGC, BHEL, SRF, SBM Money Control, 2 days ago
3:07pm IST Reuters Market Eye - Ranbaxy Laboratories ( RANB.NS ) gains 4.5 percent. Sun Pharmaceutical Industries ( SUN.NS ), which is in the process of acquiring Ranbaxy, also jumps 4.4 percent. Ranbaxy posts a profit of 4.78 billion ...Reuters India, 3 days ago Sun Pharma expects Ranbaxy turnaround by FY19 Moneycontrol.com, 3 weeks ago Sun Pharma, Ranbaxy decline in volatile trade Business Standard, 1 month ago Ranbaxy brands to stay alive Rediff.com, 2 months ago
Here are Top 10 stocks to focus on October 29 - HDFC, Crompton Greaves, ING Vysya, Jubilant Life, Nestle, Ranbaxy, PI Industries, CCL Prod, SRF, VST Industries.Money Control, 2 days ago Here are top 10 stocks to watch on Sep 18 Money Control, 1 month ago Here are top 10 stocks to keep an eye on August 25 Money Control, 2 months ago Here are top 10 stocks to focus on August 22 Money Control, 2 months ago
The agreement agreed to by Sun Pharmaceutical Industries for a buyout of Ranbaxy Laboratories from Daiichi Sankyo provides for a year's 'cooling period' during which the pay of Ranbaxy employees cannot be lowered, it is learnt. Ranbaxy is said to have also budgeted around Rs 65 crore for a retention bonus and identified 70-75 executives to distribute this. The year's cooling period is expected to start from the completion of the transaction between Sun and Daiichi, a source said. Ranbaxy ...Rediff.com, 1 week ago Ranbaxy Laboratories??? Staff Get Pay-Cut Shield In Sun Pharmaceutical Industries Ltd Buyout BioSpace, 1 week ago Top-level execs plan to quit Ranbaxy’s US subsidiary Economic Times, 2 weeks ago FDA's Surprise Visit To Sun Pharmaceutical Industries Ltd's Pressures Stock BioSpace, 1 month ago
Shares of Sun Pharmaceutical Industries and Ranbaxy Laboratories have dipped up to 4% extending their previous day's fall on reports of drug regulator, US Food and Drug Administration (FDA) conducting a surprise inspection of the Sun Pharma's ...Smart Investor, 1 month ago Top Ranbaxy executives resign in US Business Standard India, 2 weeks ago RANBAXY'S TOP EXECUTIVES IN THE US RESIGN TMC Net, 2 weeks ago Benefit of Ranbaxy deal to accrue in few years: Sun Pharma Business Standard India, 1 month ago
Shares in Sun Pharmaceutical Industries gained more than 6 per cent on Friday and heads towards biggest single-day gain since April 9. Credit Suisse says Sun has received a Form 483 from the US FDA on a Gujarat facility. FDA's Form 483 is a letter ...NDTV Profit, 1 month ago Sun Pharma stocks surge 6%, its biggest gain since April 9 Business Today India, 1 month ago Sun Pharma head towards biggest daily gain in 5-1/2 months Yahoo! Maktoob News, 1 month ago Corrected - Sun Pharma head towards biggest daily gain in 5-1/2 months Business Standard India, 1 month ago
Sun Pharmaceutical Industries is learnt to have chalked out a detailed turnaround plan for Ranbaxy Laboratories, its new purchase, even as a merger of the country's top two pharmaceutical companies is awaiting approval of the anti-trust regulator. ...Domain-B, 1 month ago Sun Pharma draws up plan to fix ailing Ranbaxy Business Standard India, 1 month ago Sun Pharma to firm up steps to boost Ranbaxy drug sales Economic Times, 1 month ago
More from: , Rediff.com...and 1 other sources
Ranbaxy Laboratories and Sun Pharmaceutical Industries are likely to be advised to sell parts of their businesses before the Competition Commission of India approves their merger. A source said the competition watchdog would by next month suggest 'structural remedies' that included selling key drug segments as conditions for clearing the country’s largest pharmaceutical industry merger. When contacted, both Sun Pharma and Ranbaxy refused to comment.On April 6, Sun Pharma announced it ...Rediff.com, 2 weeks ago
on your WebpageAdd Widget >Get your members hooked!